Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.
about
Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™.Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.Xenogene vaccination in the therapy of cancer.Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.
P2860
Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@en
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@nl
type
label
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@en
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@nl
prefLabel
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@en
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@nl
P2093
P2860
P356
P1476
Enhancement of DNA vaccine eff ...... lity complex class II pathway.
@en
P2093
Boquan Jin
Chaojun Song
J T August
Jiuyu Gong
Yongming Li
Yuanjie Sun
P2860
P304
P356
10.1002/JGM.2624
P577
2012-05-01T00:00:00Z